<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Urology reports (St. - Petersburg)</journal-id><journal-title-group><journal-title xml:lang="en">Urology reports (St. - Petersburg)</journal-title><trans-title-group xml:lang="ru"><trans-title>Урологические ведомости</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Urology reports (St. - Petersburg)</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2225-9074</issn><issn publication-format="electronic">2687-1416</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">34126</article-id><article-id pub-id-type="doi">10.17816/uroved102115-124</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original study articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Quality of life of patients with kidney stones</article-title><trans-title-group xml:lang="ru"><trans-title>Качество жизни больных нефролитиазом</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title/></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Protoshchak</surname><given-names>Vladimir V.</given-names></name><name xml:lang="ru"><surname>Протощак</surname><given-names>Владимир Владимирович</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Doctor of Medical Science, Professor, Head of Urology Department</p></bio><bio xml:lang="ru"><p>Д-р мед. наук, профессор, начальник кафедры урологии</p></bio><email>protoshakurology@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Paronnikov</surname><given-names>Mikhail V.</given-names></name><name xml:lang="ru"><surname>Паронников</surname><given-names>Михаил Валериевич</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Candidate of Medical Science, Head of Department of Urology Clinic</p></bio><bio xml:lang="ru"><p>Канд. мед. наук, заведующий отделением клиники урологии</p></bio><email>paronnikov@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sivakov</surname><given-names>Aleksei A.</given-names></name><name xml:lang="ru"><surname>Сиваков</surname><given-names>Алексей Анатольевич</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Candidate of Medical Science, Deputy Head of Urology Department</p></bio><bio xml:lang="ru"><p>Канд. мед. наук, заместитель начальника кафедры урологии</p></bio><email>alexei-sivakov@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kiselev</surname><given-names>Artem O.</given-names></name><name xml:lang="ru"><surname>Киселев</surname><given-names>Артем Олегович</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Urologist, Urological Clinic</p></bio><bio xml:lang="ru"><p>Врач-уролог клиники урологии</p></bio><email>kisart1993@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">S.M. Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation</institution></aff><aff><institution xml:lang="ru">Федеральное государственное бюджетное военное образовательное учреждение высшего образования «Военно-медицинская академия им. С.М. Кирова» Министерства обороны Российской Федерации</institution></aff><aff><institution xml:lang="zh"></institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2020-06-04" publication-format="electronic"><day>04</day><month>06</month><year>2020</year></pub-date><pub-date date-type="pub" iso-8601-date="2020-07-24" publication-format="electronic"><day>24</day><month>07</month><year>2020</year></pub-date><volume>10</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>115</fpage><lpage>124</lpage><history><date date-type="received" iso-8601-date="2020-05-20"><day>20</day><month>05</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-06-04"><day>04</day><month>06</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, Protoshchak V.V., Paronnikov M.V., Sivakov A.A., Kiselev A.O.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, Протощак В.В., Паронников М.В., Сиваков А.А., Киселев А.О.</copyright-statement><copyright-statement xml:lang="zh">Copyright ©; 2020, Protoshchak V., Paronnikov M., Sivakov A., Kiselev A.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">Protoshchak V.V., Paronnikov M.V., Sivakov A.A., Kiselev A.O.</copyright-holder><copyright-holder xml:lang="ru">Протощак В.В., Паронников М.В., Сиваков А.А., Киселев А.О.</copyright-holder><copyright-holder xml:lang="zh">Protoshchak V., Paronnikov M., Sivakov A., Kiselev A.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2023-07-24"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/uroved/article/view/34126">https://journals.eco-vector.com/uroved/article/view/34126</self-uri><abstract xml:lang="en"><p><bold>Relevance.</bold> In 2013, the Wisconsin Stone Quality of Life Questionnaire (WISQoL) was developed – a specific tool for assessing the quality of life (QoL) in patients with urolithiasis.</p> <p><bold>Aim.</bold> To determine the possibility of using the WISQoL and SF-36 questionnaires to study the treatment results of patients with kidney stones.</p> <p><bold>Materials and methods.</bold> The study included 218 patients with nephrolithiasis. Patients were divided into 2 groups: the first – the size of the stone up to 10 mm and the second – from 11 to 20 mm. At the first stage, the efficacy of treatment patients by the extracorporeal shock wave lithotripsy (ESWL) and percutaneous nephrolitholapaxy (PNL) 1 week, 1 and 3 months after surgery was compared. Questionnaires were used to study factors affecting the QOL of patients, including: gender, age, number, density and size of stones, hydronephrosis, stone free rate (SFR), type of surgery. At the next stage, the dynamics of changes in scores for the domains of questionnaires at different stages of treatment was evaluated.</p> <p><bold>Results.</bold> The efficacy of treating kidney stones up to 1 cm in size after 3 months with ESWL was 86,1% and PNL – 94,4 %, while stones up to 20 mm using ESWL – 73,4% and percutaneous techniques – 90,6%. Gender, age, stone size, SFR affected the QoL of patients with nephrolithiasis, while the number and density of stones, the presence of hydronephrosis and the type of operation were not significant. Patients 1 week after PNL had lower QoL scores in the domains of social impact and impact on vitalyty of WISQoL and mental heals of SF-36. After 1 month, these changes were determined only in the social impact domain and completely regressed by the 3<sup>rd </sup>month.</p> <p><bold>Conclusion.</bold> SFR after ESWL and PNL in the first group is comparable, in the second group, percutaneous operations were 17,2% more effective. Male gender, age up to 40 years, stone size more than 1 cm, and also not reached SFR negatively affects patients with nephrolithiasis. Compared with ESWL and PNL is accompanied by the worst dynamics of QOL scores only 1 week after the operation; upon further observation, negative changes are leveled.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Актуальность.</bold> В 2013 г. разработан Висконсинский опросник (WISQoL) — специфический инструмент для оценки качества жизни (КЖ) у больных мочекаменной болезнью.</p> <p><bold>Цель.</bold> Определение возможности использования опросников WISQoL и SF-36 для изучения результатов лечения пациентов с камнями почек.</p> <p><bold>Материалы и методы.</bold> В исследование включены 218 пациентов с нефролитиазом. Больные были разделены на 2 группы: первая — размер камня до 10 мм и вторая — от 11 до 20 мм. На первом этапе сравнивали эффективность лечения пациентов методами дистанционной литотрипсии (ДЛТ) и перкутанной нефролитолапаксии (ПНЛ) через 1 неделю, 1 и 3 месяца после операции. С помощью опросников исследовались факторы, влияющие на КЖ пациентов, среди которых: пол, возраст, количество, плотность и размер камней, гидронефроз, достигнутое состояние, свободное от камней (SFR), вид оперативного вмешательства. На следующем этапе оценивали динамику изменения баллов по доменам опросников на разных этапах лечения.</p> <p><bold>Результаты. </bold>Эффективность лечения камней почек размером до 1 см через 3 месяца методом ДЛТ составила 86,1 % и ПНЛ — 94,4 %, в то время как камней до 20 мм с помощью дистанционного дробления — 73,4 % и перкутанных методик — 90,6 %. Пол, возраст, размер камня, SFR влияли на КЖ пациентов с нефролитиазом, в то время как количество и плотность камней, наличие гидронефроза и вид операции не имели значимости. Пациенты через 1 неделю после ПНЛ имели более низкие показатели качества жизни в доменах социального функционирования и влияния на здоровье (WISQoL) и психологического функционирования SF-36. Через месяц указанные изменения определялись только в домене социального влияния и к третьему месяцу полностью регрессировали.</p> <p><bold>Заключение. </bold>SFR после ДЛТ и ПНЛ в первой группе сопоставимо, во второй группе перкутанные операции были эффективнее на 17,2 %. Мужской пол, возраст до 40 лет, размер камня более 1 см, а также не достигнутое SFR негативным образом влияет на пациентов с нефролитиазом. ПНЛ в сравнении с ДЛТ сопровождается худшей динамикой показателей качества жизни только на 1 неделе после операции, при дальнейшем наблюдении негативные изменения нивелируются.</p></trans-abstract><trans-abstract xml:lang="zh"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>urolithiasis</kwd><kwd>kidney stones</kwd><kwd>treatment effectiveness</kwd><kwd>extracorporeal shock wave lithotripsy</kwd><kwd>percutaneous nephrolitholapaxy</kwd><kwd>quality of life</kwd><kwd>Wisconsin Stone Quality of Life Questionnaire WISQoL</kwd><kwd>SF-36</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>мочекаменная болезнь</kwd><kwd>камни почек</kwd><kwd>эффективность лечения</kwd><kwd>дистанционная литотрипсия</kwd><kwd>перкутанная нефролитолапаксия</kwd><kwd>качество жизни</kwd><kwd>Висконсинский опросник WISQoL</kwd><kwd>опросник SF-36</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Heldwein FL, Sanchez-Salas RE, Sanchez-Salas R, et al. Health and quality of life in urology: issues in general urology and urological oncology. Arch Esp Urol. 2009;62(7):519-530.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Протощак В.В., Паронников М.В., Бабкин П.А., Киселев А.О. Качество жизни урологических больных // Урология. – 2018. – № 5. – С. 160–168. [Protoshchak VV, Paronnikov MV, Babkin PA, Kiselev AO. Quality of life of urological patients. Urologiia. 2018;(5):160-168. (In Russ.)]. https://doi.org/10.18565/urology.2018.5.160-168.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Новик А.А., Ионова Т.И. Руководство по исследованию качества жизни в медицине. – М.: ОЛМА-ПРЕСС Звездный мир, 2002. [Novik AA, Ionova TI. Rukovodstvo po issledovaniyu kachestva zhizni v meditsine. Moscow: OLMA-PRESS Zvezdnyy mir; 2002 (In Russ.)]</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Barry MJ, Fowler FJ, O’Leary MP, et al. The American Urological Association Symptom Index for Benign Prostatic Hyperplasia. Journal of Urology. 1992;148(5 Part 1):1549-1557. https://doi.org/10.1016/s0022-5347(17)36966-5.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Jackson MJ, Sciberras J, Mangera A, et al. Defining a patient-reported outcome measure for urethral stricture surgery. Eur Urol. 2011;60(1):60-68. https://doi.org/10.1016/j.eururo.2011.03.003.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Vij M, Srikrishna S, Robinson D, Cardozo L. Quality assurance in quality of life assessment — measuring the validity of the King’s Health Questionnaire. Int Urogynecol J. 2014;25(8):1133-1135. https://doi.org/10.1007/s00192-014-2370-5.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Coyne K, Revicki D, Hunt T, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res. 2002;11(6):563-574. https://doi.org/10.1023/a:1016370925601.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Penniston KL, Nakada SY. Development of an instrument to assess the health related quality of life of kidney stone formers. J Urol. 2013;189(3):921-930. https://doi.org/10.1016/j.juro.2012.08.247.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Penniston KL, Antonelli JA, Viprakasit DP, et al. Validation and Reliability of the Wisconsin Stone Quality of Life Questionnaire. J Urol. 2017;197(5):1280-1288. https://doi.org/10.1016/j.juro.2016.11.097.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Шестаев А.Ю., Паронников М.В., Протощак В.В., и др. Русскоязычная версия Bисконсинского опросника для оценки качества жизни у пациентов с мочекаменной болезнью (Wisconsin stone-QOL (WISQOL)): результаты пилотного исследования // Экспериментальная и клиническая урология. – 2018. – Т. 34. – № 2. – С. 50–56. [Shestaev AY, Paronnikov MV, Protoshchak VV, et al. Russian-language version of the Wisconsin questionnaire for assessing the quality of life in patients with urolithiasis (Wisconsin stone-QOL (WISQOL)): results of the pilot study. Experimental &amp; clinical urology. 2018;(2):50-57. (In Russ.)]</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Аляев Ю.Г., Глыбочко П.В., Пушкарь Д.Ю. Российские клинические рекомендации. – М.: Медфорум, 2017. [Alyaev YG, Glybochko PV, Pushkar’ DY. Rossiyskie klinicheskie rekomendatsii. Moscow: Medforum; 2017. (In Russ.)]</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Türk C, Neisius A., Petrik A, et al. Guidelines on Urolithiasis. European Association of Urology; 2019.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Knoll T, Daels F, Desai J, et al. Percutaneous nephrolithotomy: technique. World J Urol. 2017;35(9):1361-1368. https://doi.org/10.1007/s00345-017-2001-0.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>de la Rosette J, Assimos D, Desai M, et al. The Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study: indications, complications, and outcomes in 5803 patients. J Endourol. 2011;25(1):11-17. https://doi.org/10.1089/end.2010.0424.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Skolarikos A, Alivizatos G, de la Rosette JJ. Percutaneous nephrolithotomy and its legacy. Eur Urol. 2005;47(1):22-28. https://doi.org/10.1016/j.eururo.2004.08.009.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Yuri P, Hariwibowo R, Soeroharjo I, et al. Meta-analysis of Optimal Management of Lower Pole Stone of 10-20 mm: Flexible Ureteroscopy (FURS) versus Extracorporeal Shock Wave Lithotripsy (ESWL) versus Percutaneus Nephrolithotomy (PCNL). Acta Med Indones. 2018;50(1):18-25.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Bozzini G, Verze P, Arcaniolo D, et al. A prospective randomized comparison among SWL, PCNL and RIRS for lower calyceal stones less than 2 cm: a multicenter experience: A better understanding on the treatment options for lower pole stones. World J Urol. 2017;35(12):1967-1975. https://doi.org/10.1007/s00345-017-2084-7.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Ware JE, Snow KK, Kosinski M, et al. Sf-36 Health Survey. Manuel and Interpretation Guide. Lincoln, RI, USA: Quality Metric Incorporated; 2000.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Zhang H, Hong TY, Li G, et al. Comparison of the Efficacy of Ultra-Mini PCNL, Flexible Ureteroscopy, and Shock Wave Lithotripsy on the Treatment of 1-2 cm Lower Pole Renal Calculi. Urol Int. 2019;102(2):153-159. https://doi.org/10.1159/000493508.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Панферов А.С., Котов С.В., Сафиуллин Р.И. Анализ изменения качества жизни пациентов с двусторонним нефролитиазом после одномоментной и этапной билатеральной мини-перкутанной нефролитотомии // Экспериментальная и клиническая урология. – 2019. – № 1. – С. 64–69. [Panferov AS, Kotov SV, Safiullin RI. Analysis of changes in the quality of life of patients with bilateral nephrolithiasis after simultaneous and staged bilateral mini-percutaneous nephrolithotomy. Experimental &amp; clinical urology. 2019;(1):64-69. (In Russ.)] https://doi.org/10.29188/2222-8543-2019-11-1-64-69.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Stern KL, Gao T, Antonelli JA, et al. Association of Patient Age and Gender with Kidney Stone Related Quality of Life. J Urol. 2019;202(2):309-313. https://doi.org/10.1097/JU. 0000000000000291</mixed-citation></ref></ref-list></back></article>
